Endocyte, Inc. (ECYT) Tops Q4 Loss Views by 4c

Endocyte, Inc. (NASDAQ: ECYT) reported Q4 EPS of ($0.30), $0.04 better than the analyst estimate of ($0.34).

For earnings history and earnings-related data on Endocyte, Inc. (ECYT) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
• ServiceNow (NOW) Reiterated at Buy by Benchmark Into Q2 Earnings
• Green Plains Renewable Energy (GPRE) PT Raised to $20 at UBS Ahead of Q2 Results